Podcast Episode Details
Back to Podcast Episodes
An Interview With Omar Kamlin, MD, Senior Medical Director at Orphalan
Season 1 Episode 111
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Omar Kamlin, MD, senior medical director at French drugmaker Orphalan, whose therapy, Cuvrior, treats Wilson disease.
Published on 1 year, 10 months ago